On March 9, 2021 NeuBase Therapeutics, Inc. (NASDAQ: NBSE) ("NeuBase" or the "Company"), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, reported that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will present a corporate overview at the H.C. Wainwright Global Life Sciences Conference and at the Oppenheimer 31st Annual Healthcare Conference (Press release, NeuBase Therapeutics, MAR 9, 2021, View Source [SID1234576321]). Both virtual investor conferences take place in March 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:
Event: H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9th
Time: 7:00 a.m. ET
Location: Webcast Link – or at the company’s website (click here)


Event: Oppenheimer 31st Annual Healthcare Conference
Date: Wednesday, March 17th
Time: 11:20 a.m. ET
Location: Webcast Link – or at the company’s website (click here)
The webcasts from both conferences will also be archived on the NeuBase website, www.neubasetherapeutics.com.